Aesthet Surg J. 2024 Jul 15;44(8):820-828. doi: 10.1093/asj/sjae034.
Systemic symptoms associated with breast implants (SSBI) is a term used to describe a group of patients who attribute a variety of symptoms to their implants. Previous studies have shown symptom improvement after implant removal in these patients irrespective of whether part or all the implant capsule has been removed.
The aim of this study was to evaluate implant removal with no capsule removed in symptomatic and control subjects.
Eligible study subjects were sequentially enrolled at 5 investigator sites. The SSBI Cohort included patients with systemic symptoms they attributed to their implants who requested explantation. The Non-SSBI Cohort included subjects without systemic symptoms attributed to their implants who requested explantation with or without replacement. All subjects agreed to undergo explantation without removal of any capsule.
Systemic symptom improvement was noted in SSBI subjects without removal of the implant capsule, comparable to the results of our previously published study. SSBI patients showed a 74% reduction in self-reported symptoms at 6 months with no capsulectomy which was not statistically different from partial or total capsulectomies (P = .23).
Explantation with or without capsulectomy provides symptom improvement in patients with systemic symptoms they associate with their implants.
与乳房植入物相关的全身症状(SSBI)是一个术语,用于描述一组患者,他们将各种症状归因于他们的植入物。先前的研究表明,这些患者在去除植入物后,无论是否去除部分或全部包膜,症状都会改善。
本研究旨在评估在有症状和对照组中去除未去除包膜的植入物。
在 5 个研究地点按顺序招募合格的研究对象。SSBI 队列包括因植入物而出现全身症状并要求取出的患者。非 SSBI 队列包括无全身症状归因于其植入物并要求取出的受试者,无论是否更换。所有受试者均同意在不切除任何包膜的情况下进行取出。
在未切除植入物包膜的 SSBI 患者中观察到全身症状改善,与我们之前发表的研究结果相当。SSBI 患者在 6 个月时的自我报告症状减少了 74%,而无需包膜切除术,与部分或全部包膜切除术相比没有统计学差异(P=0.23)。
去除或不去除包膜的取出术可改善患者与植入物相关的全身症状。